Devices › Device types
FDA product code MTD · class 2 · Cardiovascular
Catheter, intracardiac mapping, high-density array: medical device reports filed with FDA
1,890 reports carry this product code, 1999–2026; 5 brands with a page.
- 1,890
- reports with this product code
- 0% of all MAUDE reports
- 364
- reports, 12 months to August 2026
- 376 in the 12 months before
- 69%
- classified as malfunction
- 62.3% across all reports
- 1.6%
- classified as death, as reported
- 0.9% across all reports
Product code MTD is FDA's classification for "Catheter, intracardiac mapping, high-density array" (cardiovascular panel), a class 2 device. 1,890 medical device reports carry this product code, 0% of the MAUDE database, from January 1999 to August 2026.
364 reports arrived in the 12 months to August 2026, close to the 376 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (69%), injury (28.6%) and death (1.6%). 5 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Pentaray Nav High-Density Mapping Eco Catheter | 533 | 9 | 1.3% | 68.1% |
| OCTARAY Mapping Catheter | 398 | 99 | 1.5% | 65.9% |
| Pentaray Nav | 398 | 201 | 0.8% | 92.2% |
| Advisor HD Grid Mapping Catheter, Sensor Enabled | 22 | 32 | 3.3% | 53.8% |
| Carto Vizigo 8 5f Bi-Directional Guiding Sheath Medium | 1 | 0 | 0.1% | 96.6% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Biosense Webster | 1,579 | 83.5% |
| Biosense Webster Juarez | 91 | 4.8% |
| Biosense Webster Irwindale | 22 | 1.2% |
| Boston Scientific - Costa Rica Heredia | 1 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Obstruction of flow | 465 | 24.6% |
| Patient device interaction problem | 353 | 18.7% |
| Entrapment of device | 132 | 7% |
| Detachment of device or device componentpart of the device came off | 120 | 6.3% |
| Device contamination with body fluid | 87 | 4.6% |
| Contamination /decontamination problem | 86 | 4.6% |
| Signal artifact/noise | 81 | 4.3% |
| Material twisted/bent | 74 | 3.9% |
| Coagulation in device or device ingredient | 66 | 3.5% |
| Device-device incompatibility | 59 | 3.1% |
| Breakthe device broke | 49 | 2.6% |
| Material protrusion/extrusion | 44 | 2.3% |
| Material separation | 42 | 2.2% |
| Display or visual feedback problem | 32 | 1.7% |
| Sharp edges | 30 | 1.6% |
| Material deformation | 29 | 1.5% |
| Communication or transmission problemthe device could not communicate or transmit | 28 | 1.5% |
| Improper or incorrect procedure or method | 28 | 1.5% |
| Device displays incorrect message | 22 | 1.2% |
| Difficult to removethe device was hard to remove | 21 | 1.1% |
Questions about catheter, intracardiac mapping, high-density array reports
What is product code MTD?
FDA's classification code for "Catheter, intracardiac mapping, high-density array", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.
How many reports carry this code?
1,890 reports through August 2026, 364 of them in the latest 12 months.
Which brands appear most often?
Pentaray Nav High-Density Mapping Eco Catheter (533), OCTARAY Mapping Catheter (398), Pentaray Nav (398), Advisor HD Grid Mapping Catheter, Sensor Enabled (22) and Carto Vizigo 8 5f Bi-Directional Guiding Sheath Medium (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.